Literature DB >> 19223480

Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.

Philip Bejon1, George Warimwe, Claire L Mackintosh, Margaret J Mackinnon, Sam M Kinyanjui, Jennifer N Musyoki, Peter C Bull, Kevin Marsh.   

Abstract

In studies of immunity to malaria, the absence of febrile malaria is commonly considered evidence of "protection." However, apparent "protection" may be due to a lack of exposure to infective mosquito bites or due to immunity. We studied a cohort that was given curative antimalarials before monitoring began and documented newly acquired asymptomatic parasitemia and febrile malaria episodes during 3 months of surveillance. With increasing age, there was a shift away from febrile malaria to acquiring asymptomatic parasitemia, with no change in the overall incidence of infection. Antibodies to the infected red cell surface were associated with acquiring asymptomatic infection rather than febrile malaria or remaining uninfected. Bed net use was associated with remaining uninfected rather than acquiring asymptomatic infection or febrile malaria. These observations suggest that most uninfected children were unexposed rather than "immune." Had they been immune, we would have expected the proportion of uninfected children to rise with age and that the uninfected children would have been distinguished from children with febrile malaria by the protective antibody response. We show that removing the less exposed children from conventional analyses clarifies the effects of immunity, transmission intensity, bed nets, and age. Observational studies and vaccine trials will have increased power if they differentiate between unexposed and immune children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223480      PMCID: PMC2681775          DOI: 10.1128/IAI.01358-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Immune effector mechanisms in malaria.

Authors:  K Marsh; S Kinyanjui
Journal:  Parasite Immunol       Date:  2006 Jan-Feb       Impact factor: 2.280

2.  Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Authors:  Faith H A Osier; Gregory Fegan; Spencer D Polley; Linda Murungi; Federica Verra; Kevin K A Tetteh; Brett Lowe; Tabitha Mwangi; Peter C Bull; Alan W Thomas; David R Cavanagh; Jana S McBride; David E Lanar; Margaret J Mackinnon; David J Conway; Kevin Marsh
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

3.  Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria.

Authors:  S Looareesuwan; P Wilairatana; C Viravan; S Vanijanonta; P Pitisuttithum; D E Kyle
Journal:  Am J Trop Med Hyg       Date:  1997-06       Impact factor: 2.345

4.  Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa.

Authors:  R W Snow; J A Omumbo; B Lowe; C S Molyneux; J O Obiero; A Palmer; M W Weber; M Pinder; B Nahlen; C Obonyo; C Newbold; S Gupta; K Marsh
Journal:  Lancet       Date:  1997-06-07       Impact factor: 79.321

Review 5.  European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus.

Authors:  V Puro; G De Carli; S Cicalini; F Soldani; U Balslev; J Begovac; L Boaventura; M Campins Martí; M J Hernández Navarrete; R Kammerlander; C Larsen; F Lot; S Lunding; U Marcus; L Payne; A A Pereira; T Thomas; G Ippolito
Journal:  Euro Surveill       Date:  2005-10

6.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

7.  The effects of untreated bednets on malaria infection and morbidity on the Kenyan coast.

Authors:  Tabitha W Mwangi; Amanda Ross; Kevin Marsh; Robert W Snow
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Jul-Aug       Impact factor: 2.184

8.  Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific.

Authors:  Onome J Akpogheneta; Nancy O Duah; Kevin K A Tetteh; Samuel Dunyo; David E Lanar; Margaret Pinder; David J Conway
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

9.  Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteers.

Authors:  J R Davis; J R Murphy; D F Clyde; S Baqar; A H Cochrane; F Zavala; R S Nussenzweig
Journal:  Am J Trop Med Hyg       Date:  1989-02       Impact factor: 2.345

10.  A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.

Authors:  Philip Bejon; Jedidah Mwacharo; Oscar Kai; Tabitha Mwangi; Paul Milligan; Stephen Todryk; Sheila Keating; Trudie Lang; Brett Lowe; Caroline Gikonyo; Catherine Molyneux; Greg Fegan; Sarah C Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
Journal:  PLoS Clin Trials       Date:  2006-10-20
View more
  66 in total

1.  Adjusting for heterogeneity of malaria transmission in longitudinal studies.

Authors:  Teun Bousema; Benno Kreuels; Roly Gosling
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

2.  Bayesian spatio-temporal modeling of mortality in relation to malaria incidence in Western Kenya.

Authors:  Sammy Khagayi; Nyaguara Amek; Godfrey Bigogo; Frank Odhiambo; Penelope Vounatsou
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

3.  Plasmodium falciparum var gene expression is modified by host immunity.

Authors:  George M Warimwe; Thomas M Keane; Gregory Fegan; Jennifer N Musyoki; Charles R J C Newton; Arnab Pain; Matthew Berriman; Kevin Marsh; Peter C Bull
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

4.  The relationship between reported fever and Plasmodium falciparum infection in African children.

Authors:  Emelda A Okiro; Robert W Snow
Journal:  Malar J       Date:  2010-04-19       Impact factor: 2.979

5.  Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials.

Authors:  Michael T White; Jamie T Griffin; Chris J Drakeley; Azra C Ghani
Journal:  Malar J       Date:  2010-03-23       Impact factor: 2.979

Review 6.  What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.

Authors:  Samson M Kinyanjui; Philip Bejon; Faith H Osier; Peter C Bull; Kevin Marsh
Journal:  Malar J       Date:  2009-10-28       Impact factor: 2.979

7.  Interactions between age and ITN use determine the risk of febrile malaria in children.

Authors:  Philip Bejon; Edna Ogada; Norbert Peshu; Kevin Marsh
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

Review 8.  Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data.

Authors:  Vasee S Moorthy; W Ripley Ballou
Journal:  Malar J       Date:  2009-12-30       Impact factor: 2.979

Review 9.  The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.

Authors:  Freya J I Fowkes; Jack S Richards; Julie A Simpson; James G Beeson
Journal:  PLoS Med       Date:  2010-01-19       Impact factor: 11.069

10.  Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008.

Authors:  Marielle Karine Bouyou-Akotet; Denise Patricia Mawili-Mboumba; Eric Kendjo; Modeste Mabika-Mamfoumbi; Edgard Brice Ngoungou; Arnaud Dzeing-Ella; Mireille Pemba-Mihindou; Euloge Ibinga; Emmanuel Efame-Eya; Tim Planche; Peter G Kremsner; Maryvonne Kombila
Journal:  Malar J       Date:  2009-12-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.